HRP20020428B1 - Bicyclic amino acids as pharmaceutical agents - Google Patents

Bicyclic amino acids as pharmaceutical agents

Info

Publication number
HRP20020428B1
HRP20020428B1 HR20020428A HRP20020428A HRP20020428B1 HR P20020428 B1 HRP20020428 B1 HR P20020428B1 HR 20020428 A HR20020428 A HR 20020428A HR P20020428 A HRP20020428 A HR P20020428A HR P20020428 B1 HRP20020428 B1 HR P20020428B1
Authority
HR
Croatia
Prior art keywords
amino acids
pharmaceutical agents
bicyclic amino
bicyclic
hept
Prior art date
Application number
HR20020428A
Other languages
English (en)
Croatian (hr)
Inventor
Clive Blakemore David
Receveur Jean-Marie
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of HRP20020428A2 publication Critical patent/HRP20020428A2/xx
Publication of HRP20020428B1 publication Critical patent/HRP20020428B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/22—All rings being cycloaliphatic the ring system containing eight carbon atoms, e.g. pentalene
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
HR20020428A 1999-10-20 2000-10-17 Bicyclic amino acids as pharmaceutical agents HRP20020428B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16072599P 1999-10-20 1999-10-20
PCT/US2000/028687 WO2001028978A1 (en) 1999-10-20 2000-10-17 Bicyclic amino acids as pharmaceutical agents

Publications (2)

Publication Number Publication Date
HRP20020428A2 HRP20020428A2 (en) 2005-02-28
HRP20020428B1 true HRP20020428B1 (en) 2006-02-28

Family

ID=22578159

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20040709 HRP20040709A2 (en) 1999-10-20 2000-10-17 Bicyclic amino acids as pharmaceutical agents
HR20020428A HRP20020428B1 (en) 1999-10-20 2000-10-17 Bicyclic amino acids as pharmaceutical agents

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HRP20040709 HRP20040709A2 (en) 1999-10-20 2000-10-17 Bicyclic amino acids as pharmaceutical agents

Country Status (50)

Country Link
US (2) US6689906B1 (cs)
EP (2) EP1226110B1 (cs)
JP (2) JP3632191B2 (cs)
KR (2) KR100566462B1 (cs)
CN (1) CN1165518C (cs)
AP (2) AP2002002517A0 (cs)
AR (2) AR026087A1 (cs)
AT (2) ATE358116T1 (cs)
AU (2) AU778871B2 (cs)
BG (2) BG108860A (cs)
BR (1) BR0014972B1 (cs)
CA (1) CA2386297C (cs)
CO (1) CO5280060A1 (cs)
CR (1) CR6620A (cs)
CU (1) CU23112A3 (cs)
CZ (1) CZ295960B6 (cs)
DE (2) DE60034157T2 (cs)
DO (1) DOP2000000083A (cs)
DZ (1) DZ3197A1 (cs)
EA (1) EA005206B1 (cs)
EC (1) ECSP045393A (cs)
EE (1) EE200200211A (cs)
ES (2) ES2237464T3 (cs)
GE (1) GEP20043297B (cs)
GT (2) GT200000183AA (cs)
HK (1) HK1049826B (cs)
HN (1) HN2000000224A (cs)
HR (2) HRP20040709A2 (cs)
HU (1) HUP0203325A3 (cs)
IL (3) IL164060A0 (cs)
IS (2) IS6348A (cs)
MA (1) MA26842A1 (cs)
MX (1) MXPA02003229A (cs)
MY (1) MY127678A (cs)
NO (2) NO20021780D0 (cs)
NZ (1) NZ517961A (cs)
OA (1) OA12070A (cs)
PA (1) PA8505201A1 (cs)
PE (1) PE20010740A1 (cs)
PL (1) PL354607A1 (cs)
PT (1) PT1226110E (cs)
SI (1) SI1226110T1 (cs)
SK (1) SK5232002A3 (cs)
SV (1) SV2001000188A (cs)
TR (2) TR200201094T2 (cs)
TW (2) TWI225855B (cs)
UA (1) UA72931C2 (cs)
WO (1) WO2001028978A1 (cs)
YU (2) YU29302A (cs)
ZA (1) ZA200202543B (cs)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7164034B2 (en) 1999-06-10 2007-01-16 Pfizer Inc. Alpha2delta ligands for fibromyalgia and other disorders
KR100785182B1 (ko) * 2000-06-26 2007-12-11 워너-램버트 캄파니 엘엘씨 수면 장애를 위한 가바펜틴 유사체
US6620829B2 (en) 2000-10-17 2003-09-16 Warner-Lambert Company Method of treating noninflammatory cartilage damage
EP1226820A1 (en) * 2001-01-26 2002-07-31 Warner-Lambert Company Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders
PL366406A1 (en) * 2001-04-19 2005-01-24 Warner-Lambert Company Llc Fused bicyclic or tricyclic amino acids
GB2375108A (en) * 2001-05-04 2002-11-06 Warner Lambert Co Production of a bicycloheptanone
GB2375109A (en) * 2001-05-04 2002-11-06 Warner Lambert Co Process for preparing bicyclic amino acid
IL159299A0 (en) * 2001-06-11 2004-06-01 Xenoport Inc Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
PL371944A1 (en) 2002-01-31 2005-07-11 Warner-Lambert Company Llc Alpha 2 delta ligands to treat tinnitus
IL162932A0 (en) * 2002-02-22 2005-11-20 Warner Lambert Co Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
PL375090A1 (en) * 2002-06-27 2005-11-14 Warner-Lambert Company Llc Method of treating attention deficit hyperactivity disorder
US7419981B2 (en) 2002-08-15 2008-09-02 Pfizer Inc. Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
WO2004016260A1 (en) * 2002-08-15 2004-02-26 Pfizer Limited Therapeutic use of fused bicyclic or tricyclic amino acids
GB0219024D0 (en) * 2002-08-15 2002-09-25 Pfizer Ltd Synergistic combinations
GB0223072D0 (en) 2002-10-04 2002-11-13 Pfizer Ltd Cyclic nitromethyl acetic acid derivatives
US7018818B2 (en) 2002-10-04 2006-03-28 Pfizer Inc. Intermediates in the preparation of therapeutic fused bicyclic amino acids
US7060727B2 (en) 2002-12-11 2006-06-13 Xenoport, Inc. Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof
CA2451267A1 (en) 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
KR20050085563A (ko) 2002-12-13 2005-08-29 워너-램버트 캄파니 엘엘씨 하부요로증상을 치료하기 위한 알파-2-델타 리간드
EP2172197A1 (en) 2002-12-13 2010-04-07 Warner-Lambert Company LLC Octanoic acid derivative to treat fibromyalgia and other pains
ATE449633T1 (de) 2003-09-12 2009-12-15 Pfizer Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
WO2006092692A1 (en) * 2005-03-01 2006-09-08 Pfizer Limited Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
AR061728A1 (es) * 2006-06-30 2008-09-17 Pfizer Prod Inc Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1
PL2125021T3 (pl) 2006-12-22 2011-10-31 Recordati Ireland Ltd Leczenie skojarzone zaburzeń w obrębie dolnych dróg moczowych z zastosowaniem ligandów α2δ i przeciwzapalnych leków niesterydowych (NSAIDs)
PL2192109T3 (pl) 2007-09-28 2014-01-31 Daiichi Sankyo Co Ltd Bicykliczna pochodna γ-aminokwasu
TWI462893B (zh) 2009-03-26 2014-12-01 Daiichi Sankyo Co Ltd 二環性γ－胺基酸衍生物之製造方法
JP5980780B2 (ja) 2011-06-08 2016-08-31 第一三共株式会社 クライゼン転位反応による二環性化合物の製造方法
WO2012169474A1 (ja) 2011-06-08 2012-12-13 第一三共株式会社 イミニウム塩を経由する二環性化合物の製造方法
JP6017451B2 (ja) 2011-12-15 2016-11-02 第一三共株式会社 不斉触媒を用いる二環性化合物の光学分割方法
JP6023794B2 (ja) 2012-04-10 2016-11-09 第一三共株式会社 酵素を用いる二環性化合物の光学分割方法
US9066853B2 (en) 2013-01-15 2015-06-30 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable fiber
TWI635071B (zh) 2013-07-08 2018-09-11 第一三共股份有限公司 光學活性二環γ－胺基酸衍生物及其製造方法
WO2018166855A1 (en) 2017-03-16 2018-09-20 Basf Se Heterobicyclic substituted dihydroisoxazoles
CN113045410A (zh) * 2021-03-29 2021-06-29 华东理工大学 一种双环降二萜类化合物及其合成基因及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641129A (en) * 1969-06-17 1972-02-08 Merck & Co Inc Antifibrinolytic compounds
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
CA2303244C (en) 1997-10-27 2005-12-06 Warner-Lambert Company Cyclic amino acids and derivatives thereof useful as pharmaceutical agents

Also Published As

Publication number Publication date
SK5232002A3 (en) 2003-07-01
US6689906B1 (en) 2004-02-10
US20040152779A1 (en) 2004-08-05
PA8505201A1 (es) 2002-08-29
JP3632191B2 (ja) 2005-03-23
BG108860A (en) 2006-03-31
GEP20043297B (en) 2004-01-12
GT200000183A (es) 2000-10-19
WO2001028978A1 (en) 2001-04-26
EP1506955B1 (en) 2007-03-28
EP1226110B1 (en) 2005-04-20
PT1226110E (pt) 2005-07-29
DE60034157T2 (de) 2007-12-13
BR0014972A (pt) 2002-07-16
NO20021780L (no) 2002-04-16
MA26842A1 (fr) 2004-12-20
KR100593349B1 (ko) 2006-06-26
CA2386297A1 (en) 2001-04-26
AU778871B2 (en) 2004-12-23
EP1226110A1 (en) 2002-07-31
ATE293590T1 (de) 2005-05-15
IL149143A0 (en) 2002-11-10
DOP2000000083A (es) 2002-03-30
TR200500221T2 (tr) 2005-03-21
MY127678A (en) 2006-12-29
CO5280060A1 (es) 2003-05-30
EE200200211A (et) 2003-06-16
NO20021780D0 (no) 2002-04-16
SI1226110T1 (en) 2005-08-31
AR026087A1 (es) 2002-12-26
AU2005201268A1 (en) 2005-04-21
NO20043663L (no) 2002-04-16
ECSP045393A (es) 2004-10-23
BG106719A (bg) 2003-02-28
IL164060A0 (en) 2005-12-18
TWI225855B (en) 2005-01-01
DE60019628T2 (de) 2006-01-19
NZ517961A (en) 2002-12-20
EA200200293A1 (ru) 2002-10-31
EP1506955A1 (en) 2005-02-16
CN1165518C (zh) 2004-09-08
CZ20021310A3 (cs) 2003-05-14
KR20020040900A (ko) 2002-05-30
HK1049826B (zh) 2005-02-25
ATE358116T1 (de) 2007-04-15
AU1092001A (en) 2001-04-30
ES2282785T3 (es) 2007-10-16
PE20010740A1 (es) 2001-07-27
CU23112A3 (es) 2006-02-27
IL149143A (en) 2007-02-11
KR20060013701A (ko) 2006-02-13
HN2000000224A (es) 2001-04-11
HK1049826A1 (en) 2003-05-30
JP2005036009A (ja) 2005-02-10
ZA200202543B (en) 2003-09-23
JP2003512348A (ja) 2003-04-02
TR200201094T2 (tr) 2002-09-23
MXPA02003229A (es) 2002-09-30
KR100566462B1 (ko) 2006-03-31
YU73004A (sh) 2005-11-28
SV2001000188A (es) 2001-09-07
CA2386297C (en) 2010-02-09
ES2237464T3 (es) 2005-08-01
UA72931C2 (uk) 2005-05-16
DZ3197A1 (fr) 2001-04-26
DE60019628D1 (de) 2005-05-25
TW200505824A (en) 2005-02-16
OA12070A (en) 2003-11-10
EA005206B1 (ru) 2004-12-30
HUP0203325A3 (en) 2003-12-29
CN1382118A (zh) 2002-11-27
HRP20040709A2 (en) 2004-12-31
PL354607A1 (en) 2004-01-26
HRP20020428A2 (en) 2005-02-28
YU29302A (sh) 2005-06-10
CR6620A (es) 2004-02-02
US6835751B2 (en) 2004-12-28
AP2004003186A0 (en) 2004-12-31
CZ295960B6 (cs) 2005-12-14
AR045456A2 (es) 2005-10-26
JP3744928B2 (ja) 2006-02-15
DE60034157D1 (de) 2007-05-10
GT200000183AA (es) 2005-06-17
AP2002002517A0 (en) 2002-06-30
IS7497A (is) 2004-10-08
BR0014972B1 (pt) 2011-09-06
IS6348A (is) 2002-04-17
HUP0203325A2 (hu) 2003-02-28

Similar Documents

Publication Publication Date Title
HRP20020428B1 (en) Bicyclic amino acids as pharmaceutical agents
EP1040823A3 (en) Stable foam compositions
IS2863B (is) Arípíprazóllausn til gjafar um munn
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
ATE297203T1 (de) Antithrombotische mitteln
DK0889875T3 (da) Cycloproylalkansyrederivater
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
CA2231700A1 (en) Prodrugs of aspartyl protease inhibitors
YU52000A (sh) Jedinjenja meta-azaciklične amino benzojeve kiseline i njihovi derivati, koji su antagonisti integrina
TR200201168T2 (tr) CGRP-Antagonistleri-yeni siklopropanlar içeren ilaçlar ve üretim yöntemleri.
PL377478A1 (pl) Cykloalkenowe kwasy dikarboksylowe jako środki przeciwzapalne, immunomodulujące oraz antyproliferacyjne
AU7270798A (en) Antithrombotic agents
AU4770400A (en) Fused polycyclic amino acids as pharmaceutical agents
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
ATE307809T1 (de) Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
YU87501A (sh) Farmaceutski kompleksi
DE60029979D1 (de) LIPOSOMZUSAMMENSETZUNG VON 6,9-BIS-i(2-AMINOETHYL)-AMINOöBENZOiGöISOQUINOLIN-5,10-DIONE-DIMALEAT
JO2287B1 (en) Phosphine lysis of azides and amides
AU1434201A (en) Antithrombotic agents
NO20014889D0 (no) Fremgangsmåte for fremstilling av medisinske midler
DE69824410D1 (en) Antithrombosemittel
HUP9902307A2 (hu) Új, áthidalt gyűrűs aminosavak, előállításuk és intermedierjeik

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20061002

Year of fee payment: 7

PBON Lapse due to non-payment of renewal fee

Effective date: 20071018